Could stem cell vesicles heal Crohn's fistulas? new trial underway
NCT ID NCT06918808
First seen Mar 01, 2026 · Last updated May 23, 2026 · Updated 7 times
Summary
This study tests a new treatment called DB-3Q, made from stem cell particles, for people with Crohn's disease who have painful tunnels (fistulas) near the anus. The goal is to see if it can safely close these fistulas and improve healing. About 36 adults will receive either the treatment or a placebo, and results will be checked with exams and MRI scans.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIANAL FISTULA DUE TO CROHN'S DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Columbia University Irving Medical Center/NYPH
RECRUITINGNew York, New York, 10032, United States
Contact Email: •••••@•••••
-
Direct Biologics Investigational Site
RECRUITINGAurora, Colorado, 80045, United States
-
Direct Biologics Investigational Site
RECRUITINGSt Louis, Missouri, 63130, United States
-
Direct Biologics Investigational Site
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
Direct Biologics Investigational Site
RECRUITINGNashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.